← Back to all earnings calls

Insight Molecular Diagnostics Inc. Q3 FY2023 Earnings Call

Insight Molecular Diagnostics Inc. (IMDX)

Earnings Call FY2023 Q3 Call date: 2023-11-09 Concluded

Share

Quarter scorecard

Revenue

$429,000

-57.8% YoY

Diluted EPS

$-0.81

Gross margin

57.8%

+173.2 pp YoY

Net income

-$6.49M

Documents & deck